[go: up one dir, main page]

WO2012091946A3 - Procédé pour l'inhibition de pathogènes en utilisant une composition nutritionnelle - Google Patents

Procédé pour l'inhibition de pathogènes en utilisant une composition nutritionnelle Download PDF

Info

Publication number
WO2012091946A3
WO2012091946A3 PCT/US2011/065231 US2011065231W WO2012091946A3 WO 2012091946 A3 WO2012091946 A3 WO 2012091946A3 US 2011065231 W US2011065231 W US 2011065231W WO 2012091946 A3 WO2012091946 A3 WO 2012091946A3
Authority
WO
WIPO (PCT)
Prior art keywords
nutritional composition
inhibiting
inhibiting pathogens
human
pathogens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/065231
Other languages
English (en)
Other versions
WO2012091946A2 (fr
Inventor
Anja Wittke
Cecilia MUNOZ
Dattatreya Banavara
Robert J. MCMAHON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson Nutrition Co
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/980,813 external-priority patent/US8648036B2/en
Priority claimed from US12/980,808 external-priority patent/US20120171163A1/en
Priority to RU2013128920/15A priority Critical patent/RU2013128920A/ru
Priority to BR112013011642A priority patent/BR112013011642B1/pt
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Priority to SG2013035944A priority patent/SG190781A1/en
Priority to HK14102732.3A priority patent/HK1189456B/xx
Priority to PH1/2013/500916A priority patent/PH12013500916A1/en
Priority to MX2013006094A priority patent/MX2013006094A/es
Priority to CN201180063052.8A priority patent/CN103327828B/zh
Priority to EP11809005.9A priority patent/EP2658388A2/fr
Priority to CA2822892A priority patent/CA2822892C/fr
Publication of WO2012091946A2 publication Critical patent/WO2012091946A2/fr
Publication of WO2012091946A3 publication Critical patent/WO2012091946A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pediatric Medicine (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé pour inhiber un mécanisme bactérien invasif ou d'adhérence impliquant l'administration à un être humain d'une composition nutritionnelle incluant un lipide ou une matière grasse ; une source de protéine ; une composition prébiotique ; et au moins environ 10 mg/100kCal de lactoferrine produite par une source non humaine.
PCT/US2011/065231 2010-12-29 2011-12-15 Procédé pour l'inhibition de pathogènes en utilisant une composition nutritionnelle Ceased WO2012091946A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EP11809005.9A EP2658388A2 (fr) 2010-12-29 2011-12-15 Procédé pour l'inhibition de pathogènes en utilisant une composition nutritionnelle
CA2822892A CA2822892C (fr) 2010-12-29 2011-12-15 Procede pour l'inhibition de pathogenes en utilisant une composition nutritionnelle
CN201180063052.8A CN103327828B (zh) 2010-12-29 2011-12-15 使用营养组合物抑制病原体的方法
RU2013128920/15A RU2013128920A (ru) 2010-12-29 2011-12-15 Способ ингибирования патогенов с использованием питательной композиции
SG2013035944A SG190781A1 (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition
HK14102732.3A HK1189456B (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition
PH1/2013/500916A PH12013500916A1 (en) 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition
MX2013006094A MX2013006094A (es) 2010-12-29 2011-12-15 Metodo para inhibir patogenos usando composicion nutricional.
BR112013011642A BR112013011642B1 (pt) 2010-12-29 2011-12-15 método para inibir patógenos usando uma composição nutricional

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12/980,813 2010-12-29
US12/980,813 US8648036B2 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
US12/980,808 2010-12-29
US12/980,808 US20120171163A1 (en) 2010-12-29 2010-12-29 Method for inhibiting a bacterial invasive mechanism using a nutritional composition

Publications (2)

Publication Number Publication Date
WO2012091946A2 WO2012091946A2 (fr) 2012-07-05
WO2012091946A3 true WO2012091946A3 (fr) 2012-09-07

Family

ID=45496273

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/065231 Ceased WO2012091946A2 (fr) 2010-12-29 2011-12-15 Procédé pour l'inhibition de pathogènes en utilisant une composition nutritionnelle

Country Status (13)

Country Link
EP (1) EP2658388A2 (fr)
CN (1) CN103327828B (fr)
BR (1) BR112013011642B1 (fr)
CA (1) CA2822892C (fr)
EC (1) ECSP13012798A (fr)
MX (1) MX2013006094A (fr)
MY (1) MY174494A (fr)
PE (1) PE20141192A1 (fr)
PH (1) PH12013500916A1 (fr)
RU (1) RU2013128920A (fr)
SG (2) SG10201508194RA (fr)
TW (1) TWI626893B (fr)
WO (1) WO2012091946A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
CN104994748A (zh) * 2012-12-18 2015-10-21 Mjn美国控股有限责任公司 含有乳铁蛋白的乳基营养组合物及其用途
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
EP3681511B1 (fr) * 2017-09-10 2025-10-29 Technion Research & Development Foundation Limited Composition et procédé pour un système d'administration de prébiotiques ciblant des bactéries probiotiques
GB2618609A (en) * 2022-05-13 2023-11-15 Lintbells Ltd Methods and processes for manufacture of a topically adherent selective bactericide
EP4586831A1 (fr) 2022-09-14 2025-07-23 N.V. Nutricia Composition nutritionnelle

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006121507A1 (fr) * 2005-05-05 2006-11-16 Bristol-Myers Squibb Company Utilisation de la lactoferrine bovine dans la fabrication d'un medicament destine a inhiber la croissance bacterienne
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (fr) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Composition nutraceutique comprenant de la lactoferrine et des probiotiques protéasiques
WO2009068549A1 (fr) * 2007-11-26 2009-06-04 Nestec S.A. Système de nutrition adapté à l'âge pour bébé
WO2009118771A2 (fr) * 2008-03-26 2009-10-01 Paolo Manzoni Utilisation de lactoferrine pour la prévention de sepsies néonatales chez des nouveaux-nés prématurés
WO2011051482A1 (fr) * 2009-10-29 2011-05-05 Nestec S.A. Compositions nutritionnelles contenant de la lactoferrine et des probiotiques, et nécessaires associés

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
SG49307A1 (en) 1991-01-24 1998-05-18 Martek Corp Microbial oil mixtures and use thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
JPH09509165A (ja) 1994-02-16 1997-09-16 ファーミング ベスローテン フェンノートシャップ ミルクからのラクトフェリンの分離
DK1480524T3 (da) 2002-03-07 2013-07-15 Upfront Chromatography As Fremgangsmåde til isolering af lactoferrin
CN101247823A (zh) * 2005-05-05 2008-08-20 布里斯托尔-迈尔斯斯奎布公司 牛乳铁蛋白在制备抑制细菌生长的药物中的用途
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006121507A1 (fr) * 2005-05-05 2006-11-16 Bristol-Myers Squibb Company Utilisation de la lactoferrine bovine dans la fabrication d'un medicament destine a inhiber la croissance bacterienne
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (fr) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Composition nutraceutique comprenant de la lactoferrine et des probiotiques protéasiques
WO2009068549A1 (fr) * 2007-11-26 2009-06-04 Nestec S.A. Système de nutrition adapté à l'âge pour bébé
WO2009118771A2 (fr) * 2008-03-26 2009-10-01 Paolo Manzoni Utilisation de lactoferrine pour la prévention de sepsies néonatales chez des nouveaux-nés prématurés
WO2011051482A1 (fr) * 2009-10-29 2011-05-05 Nestec S.A. Compositions nutritionnelles contenant de la lactoferrine et des probiotiques, et nécessaires associés

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] Mintel; January 2010 (2010-01-01), ANONYMOUS: "New birth formula", XP002673470, Database accession no. 1249000 *
DATABASE GNPD [online] Mintel; June 2010 (2010-06-01), ANONYMOUS: "Infant formula milk powder (stage 1)", XP002673469, Database accession no. 1337332 *
DATABASE GNPD [online] Mintel; September 2010 (2010-09-01), ANONYMOUS: "Stage 1 Baby formula powder", XP002673468, Database accession no. 1395602 *
NICOLA ORSI: "The antimicrobial activity of lactoferrin: Current status and perspectives", BIOMETALS, KLUWER ACADEMIC PUBLISHERS, BO, vol. 17, no. 3, 1 June 2004 (2004-06-01), pages 189 - 196, XP019232194, ISSN: 1572-8773, DOI: 10.1023/B:BIOM.0000027691.86757.E2 *

Also Published As

Publication number Publication date
SG10201508194RA (en) 2015-11-27
CA2822892C (fr) 2020-04-28
MX2013006094A (es) 2013-07-03
EP2658388A2 (fr) 2013-11-06
CN103327828B (zh) 2016-05-11
CN103327828A (zh) 2013-09-25
CA2822892A1 (fr) 2012-07-05
BR112013011642A2 (pt) 2016-07-12
HK1189456A1 (zh) 2014-06-13
PH12013500916A1 (en) 2024-06-03
WO2012091946A2 (fr) 2012-07-05
MY174494A (en) 2020-04-23
PE20141192A1 (es) 2014-10-01
BR112013011642B1 (pt) 2020-04-07
SG190781A1 (en) 2013-07-31
ECSP13012798A (es) 2013-09-30
RU2013128920A (ru) 2015-02-10
TW201238503A (en) 2012-10-01
TWI626893B (zh) 2018-06-21

Similar Documents

Publication Publication Date Title
WO2012091946A3 (fr) Procédé pour l'inhibition de pathogènes en utilisant une composition nutritionnelle
IN2014DN03449A (fr)
MX350325B (es) Bacteria para usarse como un probiotico para aplicaciones nutricionales y medicas.
MA33075B1 (fr) Composition destinee a la regulation du metabolism des lipides
WO2013028555A3 (fr) Procédés pour la perte de poids et compositions cétogènes
PH12013501892A1 (en) Nutritional compositions including branched chain fatty acids for wound healing
MX342733B (es) Composicion nutricional para promover el desarrollo y crecimiento sano.
BR112014009418A2 (pt) macrociclos peptidomiméticos
BR112013028709A2 (pt) cepas bacterianas capazes de metabolizar oxalatos
PH12012502318A1 (en) Substantially clear nutritional liquids comprising calcium hmb and soluble protein
WO2010007332A3 (fr) Composition de maltodextrines branchees et d'organismes eucaryotes dotes d'une paroi polysaccharidique utilisees dans le domaine du bien etre
MX338245B (es) Metodos y composicioes para inducir la saciedad.
WO2012142413A3 (fr) Compositions à base de nitrite et leurs utilisations
WO2010019212A3 (fr) Procédés d'amélioration du métabolisme énergétique
BR112014027820A2 (pt) controle dietário de doença celíaca e alergias alimentares
PH12014500796A1 (en) Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
MY161933A (en) Fortified Milk-Based Nutritional Compositions
EP2588070B8 (fr) Utilisation d'acide chicorique et de bactérie lactique pour éclaircir et / ou blanchir le teint
BR112013027474A2 (pt) composições que melhoram a palatabilidade
WO2011136573A3 (fr) Hydrolysat de levure ayant des effets de traitement de l'obésité et une activité antioxydante
WO2010119424A3 (fr) Composition destinee a la regulation du metabolisme des lipides
PH12013500761A1 (en) Cysteine and food intake
AU2011343331A8 (en) Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
MX2014001767A (es) Metodos para reducir sintomas o condiciones causados por estres.
MY162183A (en) Probiotic composition for nutraceutical product

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180063052.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11809005

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12013500916

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 001284-2013

Country of ref document: PE

WWE Wipo information: entry into national phase

Ref document number: MX/A/2013/006094

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2011809005

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2822892

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13163728

Country of ref document: CO

ENP Entry into the national phase

Ref document number: 2013128920

Country of ref document: RU

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013011642

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013011642

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130510